These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 19358266)

  • 1. Common variants in the UBC9 gene encoding the SUMO-conjugating enzyme are associated with breast tumor grade.
    Dünnebier T; Bermejo JL; Haas S; Fischer HP; Pierl CB; Justenhoven C; Brauch H; Baisch C; Gilbert M; Harth V; Spickenheuer A; Rabstein S; Pesch B; Brüning T; Ko YD; Hamann U
    Int J Cancer; 2009 Aug; 125(3):596-602. PubMed ID: 19358266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms in the UBC9 and PIAS3 genes of the SUMO-conjugating system and breast cancer risk.
    Dünnebier T; Bermejo JL; Haas S; Fischer HP; Pierl CB; Justenhoven C; Brauch H; Baisch C; Gilbert M; Harth V; Spickenheuer A; Rabstein S; Pesch B; Brüning T; Ko YD; Hamann U
    Breast Cancer Res Treat; 2010 May; 121(1):185-94. PubMed ID: 19760037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the association between genetic variation in the SUMO isopeptidase gene USPL1 and breast cancer through integration of data from the population-based GENICA study and external genetic databases.
    Bermejo JL; Kabisch M; Dünnebier T; Schnaidt S; Melchior F; Fischer HP; Harth V; Rabstein S; Pesch B; Brüning T; Justenhoven C; Brauch H; Baisch C; Ko YD; Hamann U
    Int J Cancer; 2013 Jul; 133(2):362-72. PubMed ID: 23338788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of DNA double-strand breaks repair in breast cancer is decreased in carriers of the variant allele of the UBC9 gene c.73G>A polymorphism.
    Synowiec E; Krupa R; Morawiec Z; Wasylecka M; Dziki L; Morawiec J; Blasiak J; Wozniak K
    Mutat Res; 2010 Dec; 694(1-2):31-8. PubMed ID: 20863840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphism of UBC9 gene encoding the SUMO-E2-conjugating enzyme and breast cancer risk.
    Wozniak K; Krupa R; Synowiec E; Morawiec Z
    Pathol Oncol Res; 2014 Jan; 20(1):67-72. PubMed ID: 23873416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HRM screening of the UBC9 gene encoding the SUMO-E2-conjugating enzyme - case-control study in breast cancer.
    Bialik P; Wysokinski D; Slomka M; Morawiec Z; Strapagiel D; Wozniak K
    Exp Oncol; 2020 Jun; 42(2):130-134. PubMed ID: 32602284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel mechanism whereby BRCA1/1a/1b fine tunes the dynamic complex interplay between SUMO-dependent/independent activities of Ubc9 on E2-induced ERalpha activation/repression and degradation in breast cancer cells.
    Xu J; Watkins T; Reddy A; Reddy ES; Rao VN
    Int J Oncol; 2009 Apr; 34(4):939-49. PubMed ID: 19287951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of SUMO1 and UBC9 genotypes with tumor response in non-small-cell lung cancer treated with irinotecan-based chemotherapy.
    Han JY; Lee GK; Yoo SY; Yoon SJ; Cho EY; Kim HT; Lee JS
    Pharmacogenomics J; 2010 Apr; 10(2):86-93. PubMed ID: 19859084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic Polymorphism of SUMO-Specific Cysteine Proteases - SENP1 and SENP2 in Breast Cancer.
    Mirecka A; Morawiec Z; Wozniak K
    Pathol Oncol Res; 2016 Oct; 22(4):817-23. PubMed ID: 27178176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ubc9 gene polymorphisms and late-onset Alzheimer's disease in the Korean population: a genetic association study.
    Ahn K; Song JH; Kim DK; Park MH; Jo SA; Koh YH
    Neurosci Lett; 2009 Nov; 465(3):272-5. PubMed ID: 19765634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No association of polymorphisms in the cell polarity gene SCRIB with breast cancer risk.
    Dünnebier T; Schlaefer K; Gilbert M; Baisch C; Justenhoven C; Brauch H; Harth V; Spickenheuer A; Rabstein S; Pesch B; Brüning T; Ko YD; Hamann U
    Breast Cancer Res Treat; 2011 May; 127(1):259-64. PubMed ID: 20936341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A haplotype analysis of HER-2 gene polymorphisms: association with breast cancer risk, HER-2 protein expression in the tumor, and disease recurrence in Korea.
    Han W; Kang D; Lee JE; Park IA; Choi JY; Lee KM; Bae JY; Kim S; Shin ES; Lee JE; Shin HJ; Kim SW; Kim SW; Noh DY
    Clin Cancer Res; 2005 Jul; 11(13):4775-8. PubMed ID: 16000574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of genome-wide association study newly identified genetic variants for breast cancer in Chinese women of Heilongjiang Province.
    Jiang Y; Han J; Liu J; Zhang G; Wang L; Liu F; Zhang X; Zhao Y; Pang D
    Breast Cancer Res Treat; 2011 Jul; 128(1):251-7. PubMed ID: 21197568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and activity assays for Ubc9, the ubiquitin-conjugating enzyme for the small ubiquitin-like modifier SUMO.
    Yunus AA; Lima CD
    Methods Enzymol; 2005; 398():74-87. PubMed ID: 16275321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of the progesterone receptor gene with breast cancer risk: a single-nucleotide polymorphism tagging approach.
    Pooley KA; Healey CS; Smith PL; Pharoah PD; Thompson D; Tee L; West J; Jordan C; Easton DF; Ponder BA; Dunning AM
    Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):675-82. PubMed ID: 16614108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Common genetic variation in GATA-binding protein 3 and differential susceptibility to breast cancer by estrogen receptor alpha tumor status.
    Garcia-Closas M; Troester MA; Qi Y; Langerød A; Yeager M; Lissowska J; Brinton L; Welch R; Peplonska B; Gerhard DS; Gram IT; Kristensen V; Børresen-Dale AL; Chanock S; Perou CM
    Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2269-75. PubMed ID: 18006915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A genetic variant in p63 (rs17506395) is associated with breast cancer susceptibility and prognosis.
    Zhang N; Huo Q; Wang X; Chen X; Long L; Guan X; Jiang L; Ma T; Hu W; Yang Q
    Gene; 2014 Feb; 535(2):170-6. PubMed ID: 24316488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GPR30 gene polymorphisms are associated with progesterone receptor status and histopathological characteristics of breast cancer patients.
    Giess M; Lattrich C; Springwald A; Goerse R; Ortmann O; Treeck O
    J Steroid Biochem Mol Biol; 2010 Jan; 118(1-2):7-12. PubMed ID: 19744559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tagging single nucleotide polymorphisms in the BRIP1 gene and susceptibility to breast and ovarian cancer.
    Song H; Ramus SJ; Kjaer SK; Hogdall E; Dicioccio RA; Whittemore AS; McGuire V; Hogdall C; Jacobs IJ; Easton DF; Ponder BA; Dunning AM; Gayther SA; Pharoah PD
    PLoS One; 2007 Mar; 2(3):e268. PubMed ID: 17342202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common germline genetic variation in antioxidant defense genes and survival after diagnosis of breast cancer.
    Udler M; Maia AT; Cebrian A; Brown C; Greenberg D; Shah M; Caldas C; Dunning A; Easton D; Ponder B; Pharoah P
    J Clin Oncol; 2007 Jul; 25(21):3015-23. PubMed ID: 17634480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.